Dr. Marty Pets Establishes Richfield, Wisconsin, Manufacturing Operations
03/23/2023
Golden Pet Manufacturing will be run under Dr. Marty Pets' affiliate, Golden Hippo. The new facility will enable Dr. Marty Pets to personally monitor the quality of the ingredients and source its own raw ingredients. The new food plan will increase the production to fulfill the high demand of best-selling products.
"This gives us the opportunity to trace raw ingredients, improve upon our already high-quality control and create a better sustainability story for our food products,” Dan Markenson, Head of Retail, Dr. Marty Pets said. "Our retail partners are excited about our ability to continue our great level of service as we rapidly grow our business with them."
Founded by Dr. Marty Goldstein, Dr. Marty Pets was created to help support pet health through cutting-edge, premium freeze-dried raw dog and cat food and supplements. The company’s premium pet formulas are manufactured in the U.S.
Project Announcements
GE Vernova Expands Schenectady, New York, Operations
05/26/2023
Southern Rock Energy Partners Plans Cushing, Oklahoma, Crude Oil Refinery
05/26/2023
ForwardEdge ASIC Establishes St. Paul, Minnesota, Operations
05/26/2023
Spain-Based Cosentino Group Plans Jacksonville, Florida, Manufacturing Plant
05/26/2023
Michelin Expands Junction City, Kansas, Operations
05/26/2023
Italy-Based Alpitronic Americas Plans Charlotte, North Carolina, U.S. Headquarters-Operations
05/25/2023
Most Read
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Is a Flurry of Fads Shaping Economic Development Policy?
Q2 2023
-
Nearshoring — North America’s Next Factory
Q2 2023
-
19th Annual Consultants Survey: Clients Challenged by Tight Labor Market, Energy Availability
Q1 2023
-
First Person: Labor Crunch in the Construction Industry
Q2 2023
-
Front Line: Water Supply Increasingly Affecting Location Decisions
Q2 2023
-
Manufacturing and Distribution Trends Impact the Value of Credits and Incentives
Q1 2023